Changes to telemedicine coverage for Medicare patients

Effective October 1, 2025, several telemedicine flexibilities for patients have expired. For patients insured by a government program, this impacts any upcoming virtual visits with your healthcare provider. 

Apheresis is a procedure that removes substances from a patient's blood that are contributing to patient’s disease or condition.

Patients with a variety of conditions may be recommended to have apheresis treatment, either as an inpatient or outpatient procedure.

It is important to discuss the risks, benefits and indications of each type of treatment method. 

See details, risks and benefits of the different apheresis procedures

How Do I Know If I Need Apheresis?

Clinical indications for apheresis include:

  • Thrombotic Thrombocytopenic Purpura (TTP)/aHUS (atypical hemolytic uremis syndrome)
  • Myasthenia Gravis (MG)
  • Guillain-Barre Syndrome (GBS)
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Renal/Heart/Lung Transplant with Acute Mediated Rejection
  • Chronic Lung transplant rejection or BOS (bronchiolitis obliterans syndrome)

  • ANCA-Associated Vasculitis
  • Multiple Myeloma with Hyperviscosity
  • Hypertriglyceridemia
  • Acute Leukemia with Leukostasis/Blast crisis
  • Hyperthrombocytosis
  • Sickle Cell Disease (SCD)
  • Malaria with markedly increased parasitemic load
  • Autologous/Research Stem Cell Collection